Status:
SUSPENDED
HPV Vaccine Confident Families
Lead Sponsor:
Rutgers, The State University of New Jersey
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Human Papillomavirus Vaccines
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The objectives of the study are to pilot test a tailored intervention among Black families with adolescents. The hypotheses are that the study protocol will be feasible and messages tailored to parent...
Eligibility Criteria
Inclusion
- parent or legal guardian of at least one child aged 9-13 years who has received 0 or 1 dose of HPV vaccine;
- identify as Black or African American adult;
- have access to personal mobile phone and agree to send/receive MMS messages;
- able to speak and understand English; and
- able to provide informed consent to participate
Exclusion
- parent or legal guardian of child outside of participation age range or who has completed multiple doses of HPV vaccine;
- does not identify as Black or African American adult;
- does not have personal mobile phone;
- unable to speak and understand English;
- not willing to consent to participate
Key Trial Info
Start Date :
October 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06002282
Start Date
October 1 2025
End Date
July 1 2026
Last Update
August 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rutgers
New Brunswick, New Jersey, United States, 08901